Attached files

file filename
EX-10.12 - FORWARD PURCHASE AGREEMENT - Nuvation Bio Inc.fs12020ex10-12_panaceaacq.htm
EX-10.7 - SECURITIES SUBSCRIPTION AGREEMENT, DATED MAY 7, 2020, BETWEEN THE REGISTRANT AND - Nuvation Bio Inc.fs12020ex10-7_panaceaacq.htm
EX-10.6 - SECURITIES SUBSCRIPTION AGREEMENT, DATED MAY 7, 2020, BETWEEN THE REGISTRANT AND - Nuvation Bio Inc.fs12020ex10-6_panaceaacq.htm
EX-10.2 - PROMISSORY NOTE, DATED MAY 15, 2020 ISSUED TO COWEN INVESTMENTS II LLC - Nuvation Bio Inc.fs12020ex10-2_panaceaacq.htm
EX-10.1 - PROMISSORY NOTE, DATED MAY 15, 2020 ISSUED TO ECOR1 PANACEA HOLDINGS, LLC - Nuvation Bio Inc.fs12020ex10-1_panaceaacq.htm
EX-3.3 - BYLAWS - Nuvation Bio Inc.fs12020ex3-3_panaceaacq.htm
EX-3.1 - CERTIFICATE OF INCORPORATION - Nuvation Bio Inc.fs12020ex3-1_panaceaacq.htm
S-1 - FORM S-1 - Nuvation Bio Inc.fs12020_panaceaacq.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the use in this Registration Statement on Form S-1, of our report dated June 12, 2020, relating to the balance sheet of Panacea Acquisition Corp. as of May 7, 2020, and the related statements of operations, changes in stockholders’ equity and cash flows for the period from April 24, 2020 (inception) through May 7, 2020, and to the reference to our Firm under the caption “Experts” in the Prospectus.

 

/s/ WithumSmith+Brown, PC  
   
New York, New York  
June 12, 2020